Sandu Pharmaceuticals Ltd — Important, 05-05-2026: Company Update

Sandu Pharmaceuticals has confirmed the utilization of funds raised through three preferential issues, totaling approximately Rs 5.34 crore. The company reported no deviation or variation from the stated objectives, which included revamping capital, developing marketing infrastructure, plant and machinery upgrades, and general working capital requirements. The Audit Committee reviewed and approved this statement. For the third tranche, unutilized funds are held in an Escrow account as fixed deposits. This update assures shareholders that raised capital is being deployed as planned to enhance business operations.